Megan D. Bailey - Feb 11, 2025 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
EVP, Pres, Central Labs & Intl
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Megan D. Bailey
Stock symbol
LH
Transactions as of
Feb 11, 2025
Transactions value $
$0
Form type
4
Date filed
2/13/2025, 11:50 AM
Previous filing
Feb 10, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Award $0 +3.7K $0.00 3.7K Feb 11, 2025 Common Stock 3.7K $245.14 Direct F1, F2
transaction LH Restricted Stock Unit Award $0 +1.21K +20.01% $0.00 7.26K Feb 11, 2025 Common Stock 1.21K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
F2 The option vests in three equal annual installments beginning on the date reflected in this column.
F3 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F4 The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.